Reich Kristian

Chief Scientific Officer

Reich Kristian has filed 8 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.

On the most recent filing, Reich Kristian is listed as Chief Scientific Officer at MoonLake Immunotherapeutics. Inside the rolling window, Reich Kristian reported no open-market purchases and 10 open-market sales totaling $8.1M in MLTX. The largest disclosed transaction in the window is a sale of 130,000 MLTX shares on Dec 8, 2025, worth $2.0M.

Companies traded

Other insiders at MLTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$8.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MLTXSale$22KJul 29SEC ↗
MLTXSale$1.0MJul 23SEC ↗
MLTXSale$49KJul 23SEC ↗
MLTXSale$878KJul 21SEC ↗
MLTXSale$322KJul 20SEC ↗
MLTXSale$945KJun 17SEC ↗
MLTXSale$935KJun 17SEC ↗
MLTXSale$972KJun 17SEC ↗
MLTXSale$2.0MDec 10SEC ↗
MLTXSale$1.1MDec 10SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Reich Kristian made?

Reich Kristian has filed 8 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.

Which companies does Reich Kristian trade?

Reich Kristian has filed SEC Form 4 disclosures for 1 company, including MLTX.

When was Reich Kristian's most recent SEC Form 4 filing?

Reich Kristian's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.

What is Reich Kristian's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Reich Kristian is listed as Chief Scientific Officer.

What is Reich Kristian's total buy and sell value in the current window?

Inside the rolling retention window, Reich Kristian bought $0 and sold $8.1M based on SEC Form 4 filings.

What was Reich Kristian's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 130,000 MLTX shares on 2025-12-08, worth $2.0M, per SEC Form 4 filings.